This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Innopeutics Corporation. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: The Innovative Contributions of Jae Jin Song
Introduction
Jae Jin Song is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of neurodegenerative disease research, particularly through his innovative patent.
Latest Patents
Jae Jin Song holds a patent for a composition and method aimed at inhibiting amyloid β accumulation and/or aggregation. This invention provides a technique for inhibiting amyloid β accumulation and/or aggregation by concurrently introducing Nurr1 and Foxa2 genes. The co-expression of these genes is crucial for the application of this composition in the prevention or treatment of neurodegenerative diseases, such as Alzheimer's disease.
Career Highlights
Jae Jin Song is associated with Innopeutics Corporation, where he continues to advance his research and development efforts. His work focuses on innovative solutions to combat the challenges posed by neurodegenerative diseases.
Collaborations
Some of his notable coworkers include Sang Hun Lee and Yun Seon Yang, who contribute to the collaborative efforts at Innopeutics Corporation.
Conclusion
Jae Jin Song's innovative work in the field of neurodegenerative diseases highlights the importance of research and collaboration in developing effective treatments. His contributions are paving the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile